Screener
Iovance Biotherapeutics, Inc. IOVA Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Iovance Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091716
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Product revenue, net | $99,313 | $59,952 | $170,743 | $109,276 |
| Total revenue | 99,313 | 59,952 | 170,743 | 109,276 |
| Costs and expenses * | ||||
| Cost of sales ** | $43,595 | $48,881 | $86,093 | $91,595 |
| Research and development ** | 58,851 | 77,928 | 121,338 | 153,895 |
| Selling, general, and administrative ** | 39,272 | 37,567 | 78,221 | 81,366 |
| Depreciation and amortization | 9,500 | 9,350 | 18,039 | 17,415 |
Item 1.Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Iovance Biotherapeutics, Inc.'s total revenue?
- Iovance Biotherapeutics, Inc. (IOVA) reported total revenue of $99.31M in Q2 2026.
- How has Iovance Biotherapeutics, Inc.'s total revenue changed year-over-year?
- Iovance Biotherapeutics, Inc.'s total revenue increased by 65.7% year-over-year, from $59.95M to $99.31M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s total revenue?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s total revenue has grown at a 1388.7% compound annual growth rate (CAGR), from $1.19M to $263.5M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Iovance Biotherapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude